ask="N/A"
ask_size="N/A"
average_daily_volume="513911"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.95"
change_from_200_day_moving_average="5.25"
change_from_50_day_moving_average="3.66"
change_from_52_week_high="-4.54"
change_From_52_week_low="21.51"
change_in_percent="+2.84%"
close="34.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="34.55"
high_52_weeks="38.92"
last_trade_date="1/10/2017"
last_trade_price="34.38"
last_trade_size="9272"
last_trade_time="4:00pm"
low="33.28"
low_52_weeks="12.87"
market_capitalization="1.79B"
moving_average_200_day="29.13"
moving_average_50_day="30.72"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="33.59"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+18.01%"
percent_change_from_50_day_moving_average="+11.92%"
percent_change_from_52_week_high="-11.66%"
percent_change_from_52_week_low="+167.13%"
previous_close="33.43"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.40"
price_per_sales="37.06"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="13.10"
stock_exchange="NGM"
symbol="TBPH"
volume="201229"
weeks_range_52="12.87 - 38.92"
